Drug intelligence / Profile preview

glutamine + metoclopramide + selenium + zinc

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Enteral, Parenteral, Oral, Intravenous
01

Overview

This is a combination therapy consisting of four active ingredients: - **Glutamine** (specifically L-glutamine): a non-essential amino acid important for intestinal health, immune function, and as a precursor for protein synthesis. It helps maintain the integrity of the gut barrier and supports immune cell function. - **Metoclopramide**: a dopamine D2 receptor antagonist used primarily as an antiemetic and prokinetic agent. It increases gastrointestinal motility and is also known to reverse hypoprolactinemia by antagonizing dopamine receptors. - **Selenium**: an essential trace element with antioxidant properties, incorporated into selenoproteins that protect cells from oxidative damage and support immune function. - **Zinc**: another essential trace element involved in numerous enzymatic reactions, supporting growth, wound healing, immunity, and maintaining skin hydration. This specific combination has been studied in critically ill pediatric populations to prevent stress-induced immune suppression (CRISIS) associated with nosocomial infections or sepsis. The rationale is that supplementation with zinc, selenium, glutamine (enterally), plus parenteral metoclopramide may help restore or maintain immune competence during critical illness[1][2][3]. However, clinical trials have not demonstrated significant reductions in mortality or late-onset sepsis with this regimen[3].

02

Targets

KCNQ1 (Potassium voltage-gated channel subfamily KQT member 1)DRD2 (Dopamine D2 Receptor)

Beyond the preview

Go deeper on glutamine + metoclopramide + selenium + zinc.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glutamine + metoclopramide + selenium + zinc.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call